Enveric Biosciences (ENVB) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for Enveric Biosciences
Is Enveric Biosciences a buy right now? The alternative data says hold. This ENVB stock analysis is built on the 25+ alternative data signals AltIndex tracks on Enveric Biosciences every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 40/100: a Hold. The stock trades at $1.45 with a $6M market cap.
The soft spots over the past 90 days: web traffic down 31.7% to 2K monthly visits. The rest of the signal set is holding steady, which keeps ENVB at a hold rather than a sell.
ENVB’s broader alt-data profile also covers headcount (12 employees, according to LinkedIn), Facebook followers (5K), and sentiment (100/100). Every signal links to its own page with full history, the ENVB technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on ENVB is just below.
Enveric Biosciences AI Stock Analysis
Enveric Biosciences is a biotechnology company focused on developing innovative therapeutics to treat mental health conditions. With emphasis on advanced research and development, the company aims to leverage novel approaches in addressing disorders such as anxiety and depression.
Analysis generated October 2, 2026.
Recent Enveric Biosciences Stock Alerts
|
Enveric Biosciences | August 26 Price is down by -15.8% in the last 24h. |
|
Enveric Biosciences | August 20 Price is up by 6.1% in the last 24h. |
|
Enveric Biosciences | August 19 Price is down by -7.4% in the last 24h. |
|
Enveric Biosciences | August 18 Price is down by -6.4% in the last 24h. |
Enveric Biosciences Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 2K | 31.7% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 12 | 0% | |
| Employee Recommend | 0 | N/A | |
| Business Outlook | 0 | N/A | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | 0% | |
| Stocktwits Mentions | 2 | 100.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 15K | 0.9% | |
| X Followers | 3K | 0.8% | |
| Facebook Followers | 5K | 1.0% | |
| Facebook Engagement | 3 | 0% |
About Enveric Biosciences (ENVB)
Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.
| Price | $1.45 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $6M |
| Year Range | $1 – $11 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Enveric Biosciences News
View more →
Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 SeriesSeptember 15 - Financial Post |
|
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 1 - Financial Post |
|
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026August 14 - Financial Post |
|
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003August 5 - Financial Post |
|
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug DevelopmentJuly 28 - Financial Post |
See Enveric Biosciences’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for ENVB, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEEnveric Biosciences Earnings & Financial Performance
View all earnings →Enveric Biosciences Insider Trading Activity
View all →| No recent insider transactions on file. |
Enveric Biosciences Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Enveric Biosciences
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Alzamend NeuroALZN |
$1.34 0.0% | $6M | 49 |
 |
Creative Medical TechCELZ |
$0.84 2.6% | $7M | 42 |
 |
Reviva PharmaceuticalsRVPH |
$0.50 1.0% | $7M | 46 |
 |
CollPlant BiotechnologiesCLGN |
$3.51 11.6% | $7M | 41 |
 |
NeuroSense TherapeuticsNRSN |
$3.66 2.2% | $7M | 44 |
Explore Enveric Biosciences Data
Frequently Asked Questions: Enveric Biosciences (ENVB)
Enveric Biosciences has an AltIndex AI Score of 40/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
40/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Enveric Biosciences (ENVB) stock is $1.45 with a market cap of $6M.
As of today, Enveric Biosciences’s PE (Price to Earnings) ratio is —.
View the latest Enveric Biosciences insider transactions to see recent buying and selling activity by company executives and directors.
Check the Enveric Biosciences congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The ENVB stock price chart above shows Enveric Biosciences’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Enveric Biosciences technical analysis for RSI, moving averages, and more.
See the stocks similar to Enveric Biosciences section on this page for companies in the same industry ranked by market cap and AI Score.
